Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

Drugs

Chokri Ben Lamine: Ruxolitinib - Comprehensive Clinical Reference
Aug 24, 2026, 18:13 | Drugs
Chokri Ben Lamine: Ruxolitinib - Comprehensive Clinical Reference
Chokri Ben Lamine, Hematologist at King Faisal Specialist Hospital and Research Center, shared a post…
Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
Aug 21, 2026, 10:42 | Drugs
Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
Janine Mothershed, Founder and CEO at Coding Clarified, shared a post on LinkedIn:  "What is Nplate?…
Umair Ahmad: Aspirin for Relief Protection and Prevention
Aug 4, 2026, 02:14 | Drugs
Umair Ahmad: Aspirin for Relief Protection and Prevention
Umair Ahmad, Pharmacist (Intern) at Waseem Pharmacy and Patient Counselling Centre, shared a post on…
Jack Shuang Hou: Bayer Advances Asundexian as EMA Reviews New Option for Preventing Recurrent Ischemic Stroke
Jun 11, 2026, 16:19 | Drugs
Jack Shuang Hou: Bayer Advances Asundexian as EMA Reviews New Option for Preventing Recurrent Ischemic Stroke
Jack Shuang Hou, Diagnostic Executive, Microfluidics and Immunoassay Specialist, shared on LinkedIn: ''Bayer Advances Asundexian as…
Chris Boshoff: FDA Approves Our Treatment for Hemophilia A and B for 2 New Patient Populations
Jun 9, 2026, 11:36 | Drugs
Chris Boshoff: FDA Approves Our Treatment for Hemophilia A and B for 2 New Patient Populations
Chris Boshoff, Chief Scientific Officer and President of Research and Development at Pfizer, shared on…
Akshat Jain: Marstacimab Gets FDA Expension for Children with Hemophilia B
Jun 9, 2026, 04:47 | Drugs
Akshat Jain: Marstacimab Gets FDA Expension for Children with Hemophilia B
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared a post…
Khokon Miah Akanda: FDA Approves a First-in-Class Hypertension Drug
May 30, 2026, 18:12 | Drugs
Khokon Miah Akanda: FDA Approves a First-in-Class Hypertension Drug
Khokon Miah Akanda, Senior Brand Executive at Apex Pharma Limited, shared on LinkedIn: "FDA approves a…
FDA Approves Jakafi XR (Ruxolitinib Extended-Releas) for Myelofibrosis, Polycythemia Vera and GVHD
May 4, 2026, 02:41 | Drugs
FDA Approves Jakafi XR (Ruxolitinib Extended-Releas) for Myelofibrosis, Polycythemia Vera and GVHD
Jakafi XR (ruxolitinib extended-release tablets) received U.S. Food and Drug Administration approval for the treatment…
Natalia Barajas Castrellon: FRONTIER2 Results Show Potential for Prophylactic Therapy in Hemophilia A
May 2, 2026, 14:04 | Drugs
Natalia Barajas Castrellon: FRONTIER2 Results Show Potential for Prophylactic Therapy in Hemophilia A
Natalia Barajas Castrellon, Rared Associate Director Medical and Marketing at Novo Nordisk, reposted from Novo…
Anusha Narla: Understanding Drug-Food Interaction - Levithyroxine
Apr 27, 2026, 14:33 | Drugs
Anusha Narla: Understanding Drug-Food Interaction - Levithyroxine
Anusha Narla, Academic Team Lead at Medclinigen, shared a post on LinkedIn: "Understanding drug-food interaction:…
All: 97 Posts: 1 - 10
NewsFeed